(Q30379637)

21 June 2017

title

25 years of HIV research! ... and what about a vaccine? (English)

1 reference

21 June 2017

Victor Appay

1

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

European Journal of Immunology

21 June 2017

published in

1 reference

21 June 2017

volume

39

1 reference

21 June 2017

issue

8

1 reference

21 June 2017

page(s)

1999-2003

1 reference

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

HIV pathogenesis: 25 years of progress and persistent challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200939551

1 reference

7 January 2021

HIV vaccine research: the way forward

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

CD8+ T cell efficacy in vaccination and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Impact of MHC class I diversity on immune control of immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

The avidity and lytic efficiency of the CTL response to HTLV-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Complete but curtailed T-cell response to very low-affinity antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200939551

1 reference

7 January 2021

miR-181a is an intrinsic modulator of T cell sensitivity and selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Vaccine adjuvants alter TCR-based selection thresholds.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Adaptation of HIV-1 to human leukocyte antigen class I

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Design and pre-clinical evaluation of a universal HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Update on animal models for HIV research

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939551

7 January 2021

Identifiers

DOI

10.1002/EJI.200939551

1 reference

21 June 2017

1 reference